Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GNAI3 | P08754 | 1/20 | 0.50 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.50 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.50 |
| ▸ | NAAA | Q02083 | 2/20 | 0.42 |
| ▸ | CES2 | O00748 | 3/20 | 0.39 |
| ▸ | CES1 | P23141 | 3/20 | 0.39 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.38 |
| ▸ | PPARG | P37231 | 7/20 | 0.38 |
| ▸ | PPARD | Q03181 | 7/20 | 0.38 |
| ▸ | PPARA | Q07869 | 7/20 | 0.38 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.38 |
| ▸ | TSHR | P16473 | 4/20 | 0.38 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | TLR2 | O60603 | 2/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.38 |
| ▸ | FABP4 | P15090 | 2/20 | 0.38 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.38 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6264306 | 0.81 | GNAI3 (0.42) | GNAI3GNAO1GNAI1NAAACES2 | |
| SCHEMBL9130901 | 0.79 | TDP1 (0.43) | CES2CES1GPR84PPARGPPARD | |
| SCHEMBL2478384 | 0.75 | CES2 (0.45) | CES2CES1GPR84PPARGPPARD | |
| Palmitic Acid SCHEMBL28389718 | 0.74 | GPR84 (0.71) | GNAI3GNAO1GNAI1GPR84PPARG | |
| SCHEMBL1041620 | 0.73 | NAAA (0.43) | GNAI3GNAO1GNAI1NAAACES2 | |
| Stearic Acid SCHEMBL28352709 | 0.70 | GPR84 (0.63) | GNAI3GNAO1GNAI1NAAAGPR84 | |
| Dodecanoate SCHEMBL972888 | 0.69 | GPR84 (0.61) | GNAI3GNAO1GNAI1NAAAGPR84 | |
| SCHEMBL10972650 | 0.69 | GNAI3 (0.53) | GNAI3GNAO1GNAI1NAAACES2 | |
| Behenic Acid SCHEMBL11790871 | 0.69 | GPR84 (0.61) | GNAI3GNAO1GNAI1NAAAGPR84 | |
| Stearic Acid SCHEMBL8467872 | 0.69 | GPR84 (0.61) | GNAI3GNAO1GNAI1NAAAGPR84 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1658819-A | Care and/or make-up cosmetic composition structured with silicone polymers and organogelling agents, in rigid form | OREAL (FR) | 2005-08-24 | — | — | CN | claimed |
| EP-1515684-A2 | CARE AND/OR MAKE-UP COSMETIC COMPOSITION STRUCTURED WITH SILICONE POLYMERS AND ORGANOGELLING AGENTS, IN RIGID FORM | L'OREAL (FR) | 2005-03-23 | — | — | EP | claimed |
| WO-2003105788-A2 | CARE AND/OR MAKE-UP COSMETIC COMPOSITION STRUCTURED WITH SILICONE POLYMERS AND ORGANOGELLING AGENTS, IN RIGID FORM | L'OREAL (FR) | 2003-12-24 | — | — | WO | claimed |
| EP-1294342-A2 | COMPOSITION STRUCTURED WITH A POLYMER CONTAINING AHETEROATOM AND AN ORGANOGELATOR | L'OREAL (FR) | 2003-03-26 | — | — | EP | claimed |
| WO-2002055030-A2 | COMPOSITION STRUCTURED WITH A POLYMER CONTAINING A HETEROATOM AND ORGANOGELATOR | OREAL (FR) | 2002-07-18 | — | — | WO | claimed |
| WO-2002005763-A1 | COSMETIC OR PHARMACEUTICAL COMPOSITION IN SOLID FORM COMPRISING BIS-ACYL-AMIDES | L'OREAL (FR) | 2002-01-24 | — | — | WO | claimed |
| EP-1174110-A1 | Cosmetic or pharmaceutical solid composition comprising bis-acyl-amides | L'OREAL (FR) | 2002-01-23 | — | — | EP | claimed |
| CN-100581529-C | Care and/or make-up cosmetic composition structured with silicone polymers and organogelators in rigid form | OREAL | 2010-01-20 | — | — | CN | disclosed |
| CN-1997346-A | Composition structured with a polymer containing hetero atoms and an organogelator | OREAL (FR) | 2007-07-11 | — | — | CN | disclosed |
| CN-1658819-A | Care and/or make-up cosmetic composition structured with silicone polymers and organogelling agents, in rigid form | OREAL (FR) | 2005-08-24 | — | — | CN | disclosed |
| EP-1515684-A2 | CARE AND/OR MAKE-UP COSMETIC COMPOSITION STRUCTURED WITH SILICONE POLYMERS AND ORGANOGELLING AGENTS, IN RIGID FORM | L'OREAL (FR) | 2005-03-23 | — | — | EP | disclosed |
| WO-2003105788-A2 | CARE AND/OR MAKE-UP COSMETIC COMPOSITION STRUCTURED WITH SILICONE POLYMERS AND ORGANOGELLING AGENTS, IN RIGID FORM | L'OREAL (FR) | 2003-12-24 | — | — | WO | disclosed |
| US-20030091520-A1 | Use of at least one polar additive in a cosmetic composition comprising a liquid fatty phase structured by at least one molecular organogelator, to impart a thixotropic character to the composition | L'OREAL (FR) | 2003-05-15 | — | — | US | disclosed |
| CN-1386063-A | Cosmetic or pharmaceutical solid composition comprising bis-acyl-amides | OREAL (FR) | 2002-12-18 | — | — | CN | disclosed |
| EP-1264589-A1 | Use of a polar additive in a cosmetic composition containing a structured liquid oil phase by at least one organogelator to give a thixotropic character | L'OREAL (FR) | 2002-12-11 | — | — | EP | disclosed |
| WO-2002005763-A1 | COSMETIC OR PHARMACEUTICAL COMPOSITION IN SOLID FORM COMPRISING BIS-ACYL-AMIDES | L'OREAL (FR) | 2002-01-24 | — | — | WO | disclosed |
| EP-1174110-A1 | Cosmetic or pharmaceutical solid composition comprising bis-acyl-amides | L'OREAL (FR) | 2002-01-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030091520-A1 | Use of at least one polar additive in a cosmetic composition comprising a liquid fatty phase structured by at least one molecular organogelator, to impart a thixotropic character to the composition | PLIN3, CUTA, FABP4 | GNAI3 1907/4885GNAO1 3552/4885GNAI1 3527/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.